Literature DB >> 19502211

Late-night salivary cortisol for the diagnosis of Cushing syndrome: a meta-analysis.

Ty Carroll1, Hershel Raff, James W Findling.   

Abstract

OBJECTIVE: To report a meta-analysis of late-night salivary cortisol testing for the diagnosis of Cushing syndrome.
METHODS: MEDLINE and EMBASE computer databases were searched to identify relevant articles published between January 1950 and December 2007. The search strategy used the following medical subject headings and keywords: cortisol, Cushing or Cushing's, saliva, salivary, late-night, nocturnal, and nighttime. The results were limited to studies in humans older than 18 years. Titles and abstracts of all articles, as well as full text of relevant articles, were reviewed. Sensitivity, specificity, likelihood ratio positive, likelihood ratio negative, and diagnostic odds ratio were extracted by 2 authors. Discrepancies were resolved by mediation and discussion with a third author.
RESULTS: Seven articles contained sufficient information to be included in the analysis. A total of 947 patients (339 with Cushing syndrome) were identified. Pooled data from the 7 studies revealed a sensitivity of 92% (95% confidence interval [CI], 88%-94%), specificity of 96% (95% CI, 94%-97%), and diagnostic odds ratio of 311 (95% CI, 92-1059). Likelihood ratio positive was 21 (95% CI, 10-43), with a likelihood ratio negative of 0.08 (95% CI, 0.02-0.32). Inconsistencies for each of these results measured by the I2 statistic ranged from moderate to high.
CONCLUSION: This analysis demonstrates that late night salivary cortisol has excellent diagnostic characteristics and as such, is a robust, convenient test for screening and diagnosis of Cushing syndrome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19502211     DOI: 10.4158/EP09023OR

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  27 in total

1.  Salivary cortisol and the diagnosis of Cushing's syndrome: a coming of age.

Authors:  Hershel Raff
Journal:  Endocrine       Date:  2012-06       Impact factor: 3.633

2.  Biomarkers: Salivary cortisol or cortisone?

Authors:  Hershel Raff; James W Findling
Journal:  Nat Rev Endocrinol       Date:  2010-12       Impact factor: 43.330

Review 3.  Cushing's syndrome: diagnosis and surveillance using salivary cortisol.

Authors:  Hershel Raff
Journal:  Pituitary       Date:  2012-03       Impact factor: 4.107

Review 4.  Pros and cons of screening for occult Cushing syndrome.

Authors:  Antoine Tabarin; Paul Perez
Journal:  Nat Rev Endocrinol       Date:  2011-03-22       Impact factor: 43.330

Review 5.  Update on late-night salivary cortisol for the diagnosis of Cushing's syndrome: methodological considerations.

Authors:  Hershel Raff
Journal:  Endocrine       Date:  2013-07-10       Impact factor: 3.633

6.  Urine free cortisol in the diagnosis of Cushing's syndrome: is it worth doing and, if so, how?

Authors:  Hershel Raff; Richard J Auchus; James W Findling; Lynnette K Nieman
Journal:  J Clin Endocrinol Metab       Date:  2014-11-25       Impact factor: 5.958

7.  Systematic reviews of diagnostic tests in endocrinology: an audit of methods, reporting, and performance.

Authors:  Gabriela Spencer-Bonilla; Naykky Singh Ospina; Rene Rodriguez-Gutierrez; Juan P Brito; Nicole Iñiguez-Ariza; Shrikant Tamhane; Patricia J Erwin; M Hassan Murad; Victor M Montori
Journal:  Endocrine       Date:  2017-06-05       Impact factor: 3.633

8.  Role of cortisol in mood and memory in patients with intractable temporal lobe epilepsy.

Authors:  R M Busch; T Frazier; J S Chapin; A H Hamrahian; B Diehl; A Alexopoulos; K Unnwongse; R I Naugle; C S Kubu; G E Tesar; I M Najm
Journal:  Neurology       Date:  2012-03-21       Impact factor: 9.910

Review 9.  Cushing's syndrome: from physiological principles to diagnosis and clinical care.

Authors:  Hershel Raff; Ty Carroll
Journal:  J Physiol       Date:  2015-01-05       Impact factor: 5.182

10.  Midnight salivary cortisol for the diagnosis of Cushing's syndrome in a Chinese population.

Authors:  Dao-Chen Lin; Pei-Shan Tsai; Yi-Chun Lin
Journal:  Singapore Med J       Date:  2018-11-29       Impact factor: 1.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.